114 related articles for article (PubMed ID: 1471235)
1. Behavioral toxicity of guanidinosuccinic acid in adult and young mice.
D'Hooge R; Pei YQ; Marescau B; De Deyn PP
Toxicol Lett; 1992 Dec; 64-65 Spec No():773-7. PubMed ID: 1471235
[TBL] [Abstract][Full Text] [Related]
2. The uremic guanidino compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice.
D'Hooge R; Pei YQ; Manil J; De Deyn PP
Brain Res; 1992 Dec; 598(1-2):316-20. PubMed ID: 1486493
[TBL] [Abstract][Full Text] [Related]
3. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
D'Hooge R; Pei YQ; Marescau B; De Deyn PP
J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
[TBL] [Abstract][Full Text] [Related]
4. Ontogenetic differences in convulsive action and cerebral uptake of uremic guanidino compounds in juvenile mice.
D'Hooge R; Pei YQ; Marescau B; De Deyn PP
Neurochem Int; 1994 Mar; 24(3):215-20. PubMed ID: 8025530
[TBL] [Abstract][Full Text] [Related]
5. Epileptiform activity and hippocampal damage produced by intrahippocampal injection of guanidinosuccinic acid in rat.
Pan JC; Pei YQ; An L; Lai L; D'Hooge R; De Deyn PP
Neurosci Lett; 1996 May; 209(2):121-4. PubMed ID: 8761997
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptors contribute to guanidinosuccinate-induced convulsions in mice.
D'Hooge R; Pei YQ; De Deyn PP
Neurosci Lett; 1993 Jul; 157(2):123-6. PubMed ID: 7901812
[TBL] [Abstract][Full Text] [Related]
7. GSA: behavioral, histological, electrophysiological and neurochemical effects.
Torremans A; Marescau B; Van Dam D; Van Ginneken C; Van Meir F; Van Bogaert PP; D'Hooge R; de Vente J; De Deyn PP
Physiol Behav; 2005 Feb; 84(2):251-64. PubMed ID: 15708777
[TBL] [Abstract][Full Text] [Related]
8. [Seizure activity and lesions of neuronal cells by intrahippocampal injection of guanidinosuccinic acid in rats].
Pan JC; Pei YQ; An L; Lai L
Yao Xue Xue Bao; 1996; 31(8):561-7. PubMed ID: 9772701
[TBL] [Abstract][Full Text] [Related]
9. Guanidino compound levels in brain regions of non-dialyzed uremic patients.
De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C
Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461
[TBL] [Abstract][Full Text] [Related]
10. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
Maejima M; Takahashi S; Hatano M
Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.
Kopple JD; Gordon SI; Wang M; Swendseid ME
J Lab Clin Med; 1977 Aug; 90(2):303-11. PubMed ID: 886215
[TBL] [Abstract][Full Text] [Related]
12. Comparison of toxic effects of methylguanidine, guanidinosuccinic acid and creatinine in rats with adenine-induced chronic renal failure.
Yokozawa T; Mo ZL; Oura H
Nephron; 1989; 51(3):388-92. PubMed ID: 2918950
[TBL] [Abstract][Full Text] [Related]
13. [Guanidinosuccinic acid and uremia. II. Animal experiment findings].
Dobbelstein H; Grunst J; Schubert G; Edel HH
Klin Wochenschr; 1971 Oct; 49(19):1077-83. PubMed ID: 5115326
[No Abstract] [Full Text] [Related]
14. Endogenous guanidino compounds as uremic neurotoxins.
De Deyn PP; D'Hooge R; Van Bogaert PP; Marescau B
Kidney Int Suppl; 2001 Feb; 78():S77-83. PubMed ID: 11168988
[TBL] [Abstract][Full Text] [Related]
15. Involvement of voltage- and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins.
D'Hooge R; Van de Vijver G; Van Bogaert PP; Marescau B; Vanholder R; De Deyn PP
Kidney Int; 2003 May; 63(5):1764-75. PubMed ID: 12675852
[TBL] [Abstract][Full Text] [Related]
16. Behavioral differences between subgroups of rats with high and low threshold to clonic convulsions induced by DMCM, a benzodiazepine inverse agonist.
Contó MB; de Carvalho JG; Benedito MA
Pharmacol Biochem Behav; 2005 Nov; 82(3):417-26. PubMed ID: 16297441
[TBL] [Abstract][Full Text] [Related]
17. Role of reactive oxygen and argininosuccinate in guanidinosuccinate synthesis in isolated rat hepatocytes.
Aoyagi K; Nagase S; Gotoh M; Akiyama K; Satoh M; Hirayama A; Koyama A
Enzyme Protein; 1996; 49(4):205-11. PubMed ID: 9030887
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of guanidinosuccinate from argininosuccinate and reactive oxygen in vitro.
Aoyagi K; Nagase S; Tomida C; Takemura K; Akiyama K; Koyama A
Enzyme Protein; 1996; 49(4):199-204. PubMed ID: 9030886
[TBL] [Abstract][Full Text] [Related]
19. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
De Deyn PP; Macdonald RL
Ann Neurol; 1990 Nov; 28(5):627-33. PubMed ID: 2135950
[TBL] [Abstract][Full Text] [Related]
20. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
